Pfizer and BioNTech say bivalent booster increases neutralizing antibodies against new omicron variantsMarket Watch • 11/18/22
Pfizer and BioNTech Report New Data on Omicron BA.4/BA.5-Adapted Bivalent Booster Demonstrating Improved Immune Response Against Emerging Omicron SublineagesGlobeNewsWire • 11/18/22
Pfizer, BioNTech Take Next Step Toward A Pan-Covid Vaccine — But Is The Demand There?Investors Business Daily • 11/17/22
Pfizer and BioNTech Advance Next-Generation COVID-19 Vaccine Strategy with Study Start of Candidate Aimed at Enhancing Breadth of T cell Responses and Duration of ProtectionGlobeNewsWire • 11/16/22
Moderna Surges On New Omicron Data, Pulling Pfizer, BioNTech Along For The RideInvestors Business Daily • 11/14/22
BioNTech Expands Global Footprint by Acquiring GMP Manufacturing Site to Establish First mRNA Facility in SingaporeGlobeNewsWire • 11/14/22
Pfizer, BioNTech BA.4/BA.5-adapted booster gets CHMP recommendation for 5-11 year olds in EUMarket Watch • 11/10/22
Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine Booster for Children 5 Through 11 Years of Age in European UnionGlobeNewsWire • 11/10/22
BioNTech Takes A Hit Despite Doubling Profit Views, Raising 2022 OutlookInvestors Business Daily • 11/07/22
BioNTech profit and revenue fall sharply from year-ago period but top estimatesMarket Watch • 11/07/22
This Key Piece Of News Could Sparked BioNTech, Moderna — And Could Stoke Demand For Covid BoostersInvestors Business Daily • 11/04/22
Pfizer-BioNTech bivalent booster shows higher immune response, but new COVID cases climb back above 40,000 a dayMarket Watch • 11/04/22
Pfizer, BioNTech stocks rally after announcing positive trial data on BA.4/BA.5 bivalent booster shotMarket Watch • 11/04/22
Pfizer and BioNTech Announce Updated Clinical Data for Omicron BA.4/BA.5-Adapted Bivalent Booster Demonstrating Substantially Higher Immune Response in Adults Compared to the Original COVID-19 VaccineBusiness Wire • 11/04/22
BioNTech stock surges toward 3-month high after report China agrees to approve its COVID vaccine for foreignersMarket Watch • 11/04/22